Erytech Pharma SA ADR (ERYP)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

60 AVENUE ROCKEFELLER LYON, FRANCE 69008

Erytech Pharma S.A. operates as a biopharmaceutical company. The Company discovers and developes therapies for rare forms of cancer and orphan diseases. Erytech Pharma serves customers in France and the United States.

Data based on most recent fiscal year report
Market Cap347.707 Million Shares Outstanding17.12 Million Avg Volume4.619 Thousand
1-Yr BETA vs S&P TR1.102 Current Ratio6.71 Quick Ratio6.68
View SEC Filings from ERYP instead.
Q4 2018 All Institutions Hedge Funds 1
To trade ERYP now:
Filers who had this stock in their top 10: 0 0 (0.0%)
13F Filers holding this stock: 6 2 (0.2%)
Aggregate 13F shares on 12/31/2018: 1.464 Million 648.682 Thousand
Aggregate 13F shares on 09/30/2018: 2.631 Million 1.815 Million
Percent change: -44.37% -64.26%
Funds creating new positions:
Funds Adding to an existing position:
Funds closing out their position: 3 2
Funds reducing their position: 1 1
1 hedge funds as identified by whalewisdom.com through public filings.

Funds Holding ERYP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions

**EXPERIMENTAL** Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin
RENAISSANCE TECHNOLOGIES LLC ERYTECH PHARMA 0.51% 2018-01-02 FRANCE

Short Position History

Holder Net Short Position Position Date Origin
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 0.7% 2015-04-27 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 1.38% 2016-04-20 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 0.68% 2017-12-11 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 1.69% 2016-04-05 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 1.59% 2015-10-23 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 0.69% 2016-06-22 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 1.7% 2015-11-23 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 1.6% 2015-10-22 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 0.61% 2015-04-07 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 1.79% 2016-03-17 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 1.8% 2016-03-09 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 0.54% 2015-03-31 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 0.7% 2017-12-14 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 0.79% 2016-06-09 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 1.19% 2016-05-04 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 1.3% 2015-08-21 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 1.6% 2015-10-26 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 1.51% 2015-12-08 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 0.5% 2016-09-12 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 0.49% 2016-11-03 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 1.09% 2015-06-18 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 1.29% 2016-04-26 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 0.68% 2017-12-15 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 1.58% 2016-04-11 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 1.1% 2015-06-16 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 1.09% 2016-05-12 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 1.5% 2015-10-12 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 1.59% 2015-12-18 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 0.49% 2016-08-04 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 1.2% 2015-07-27 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 0.98% 2016-05-24 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 0.59% 2016-07-07 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 0.87% 2016-05-31 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 1.49% 2016-04-14 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 1.0% 2015-05-26 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 0.5% 2017-12-06 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 0.92% 2015-05-19 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 1.73% 2016-03-02 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 1.1% 2015-06-22 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 1.61% 2016-02-17 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 1.4% 2015-09-24 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 0.81% 2015-05-11 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 1.6% 2015-12-16 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 0.48% 2018-01-08 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 0.53% 2018-01-05 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 0.5% 2017-11-10 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 1.49% 2016-01-07 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 0.35% 2017-11-14 FRANCE
GSA CAPITAL PARTNERS L.L.P. ERYTECH PHARMA 1.5% 2016-02-08 FRANCE
Click here to report any possible errors with this stock listing.

Elevate your investments